Skip to main content

Breadcrumb

  1. Home

Paper Patient Medical Records

Valid for Measure Submission

CAC-2 Systemic corticosteroids for Inpatient Asthma

  • Use of systemic corticosteroids in pediatric asthma patients (age 2 through 17 years) admitted for inpatient treatment of asthma. This measure is a part of a set of three nationally implemented measures that address children’s asthma care (CAC-1: Relievers for Inpatient Asthma, CAC-3: Home Management Plan of Care (HMPC) Document Given to Parent/Caregiver) that are used in The Joint Commission’s accreditation process.

    CBE ID
    0144

Cardiac Rehabilitation Patient Referral From an Inpatient Setting

  • Percentage of patients admitted to a hospital with a primary diagnosis of an acute myocardial infarction or chronic stable angina or who during hospitalization have undergone coronary artery bypass (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery (CVS), or cardiac transplantation who are referred to an early outpatient cardiac rehabilitation/secondary prevention program.

    CBE ID
    0642

Care for Older Adults (COA) – Medication Review

  • Percentage of adults 65 years and older who had a medication review during the measurement year. A medication review is a review of all a patient’s medications, including prescription medications, over-the-counter (OTC) medications and herbal or supplemental therapies by a prescribing practitioner or clinical pharmacist.

    CBE ID
    0553

Central Line Bundle Compliance

  • Percentage of intensive care patients with central lines for whom all
    elements of the central line bundle are documented and in place.
    The central line bundle elements include:
    •Hand hygiene
    •Maximal barrier precautions upon insertion
    •Chlorhexidine skin antisepsis
    •Optimal catheter site selection, with avoidance of the femoral vein for central venous access in patients 18 years and older
    •Daily review of line necessity with prompt removal of unnecessary lines

    CBE ID
    0298

Cervical Cancer Screening

  • The percentage of women 21–64 years of age who were screened for cervical cancer using either of the following criteria:
    -Women 21–64 years of age who had cervical cytology performed within the last 3 years.
    -Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
    -Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years.

    CBE ID
    0032

Childhood Immunization Status (CIS)

  • Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DtaP); three polio (IPV); one measles, mumps and rubella (MMR); three haemophilus influenza type B (HiB); three hepatitis B (HepB); one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (HepA); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine.

    CBE ID
    0038

Chlamydia Screening and Follow Up

  • The percentage of female adolescents 18 years of age who had a chlamydia screening test with proper follow-up.

    CBE ID
    1395

Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients

  • Percentage of patients aged 18 years through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy or have previously received adjuvant chemotherapy within the 12-month reporting period

    CBE ID
    0385e